Half Year 2019 Poxel SA Earnings Call Transcript
Ladies and gentlemen, welcome to the Poxel conference call. I now hand over to Jonae Barnes. Madame, please go ahead.
Thank you for joining us today for Poxel's Half Year 2019 Financial Results and Corporate Update. I'm Jonae Barnes, Senior Vice President, Investor Relations and Public Relations. With me on the call is Thomas Kuhn, CEO; Anne Renevot, CFO; Noah Beerman, President of U.S. Operations and EVP of Business Development; Sébastien Bolze, Nonclinical Development; Christophe Arbet-Engels, Chief Medical Officer, EVP Late Development and Medical Affairs; and Pascale Fouqueray-Grellier, EVP Translational Medicine and Early Clinical Development.
Before we open up the call to the question-and-answer session, we will begin with a brief overview from Thomas Kuhn, CEO. Anne Renevot, our CFO, will provide a summary of the 2019 half year financial results, and then Thomas will review our half year 2019 accomplishments and significant upcoming milestones for the remainder of 2019 and 2020.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
